Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-01-04 @ 4:41 PM
Study NCT ID:
NCT01668004
Status:
COMPLETED
Last Update Posted:
2019-02-04
First Post:
2012-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2015-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-01
First Submit QC Date:
None
Study First Post Date:
2012-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-15
Results First Submit QC Date:
None
Results First Post Date:
2016-08-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-16
Last Update Post Date:
2019-02-04
Last Update Post Date Type:
ACTUAL